EMMER GREEN SURGERY — All Prescriptions & Medications — Page 2
Practice Code: K81041 | READING, RG4 8RA
Showing results 51-100 of 571
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Nitrofurantoin | 752 | 9,328 | £5.1K | +57.6% ▲ |
| Progesterone | 748 | 54.7K | £10.9K | +78.7% ▲ |
| Spironolactone | 735 | 28.9K | £7.5K | +36.3% ▲ |
| Candesartan cilexetil | 721 | 34.5K | £1.4K | -39.2% ▼ |
| 716 | 10.3K | £7.1K | +7.8% ▲ | |
| Fluticasone propionate (Inhalation) | 707 | 1,015 | £25.0K | +82.7% ▲ |
| Zopiclone | 699 | 16.2K | £730 | +26.2% ▲ |
| Glucose blood testing reagents | 678 | 68.1K | £7.6K | -14.1% ▼ |
| Duloxetine hydrochloride | 677 | 33.3K | £2.4K | +6.5% ▲ |
| Mometasone furoate | 674 | 807 | £6.3K | +67.9% ▲ |
| Flucloxacillin sodium | 665 | 27.7K | £1.5K | +47.9% ▲ |
| Dapagliflozin | 661 | 26.2K | £32.5K | -47.2% ▼ |
| Hydrocortisone | 615 | 21.2K | £5.7K | +37.2% ▲ |
| Finasteride | 606 | 26.9K | £950 | -7.5% ▼ |
| Sildenafil (Erectile Dysfunction) | 606 | 3,340 | £749 | +20.2% ▲ |
| Diazepam | 602 | 20.9K | £448 | +20.9% ▲ |
| Warfarin sodium | 600 | 33.7K | £1.2K | +27.2% ▲ |
| Fluoxetine hydrochloride | 588 | 40.3K | £1.9K | -42.0% ▼ |
| Hydroxocobalamin | 587 | 1,018 | £2.2K | +22.0% ▲ |
| Betamethasone valerate | 585 | 43.5K | £3.8K | +51.9% ▲ |
| Bendroflumethiazide | 581 | 25.6K | £1.1K | -24.9% ▼ |
| Quetiapine | 579 | 34.0K | £5.1K | -7.0% ▼ |
| Montelukast | 578 | 21.9K | £1.1K | -15.6% ▼ |
| Donepezil hydrochloride | 574 | 14.4K | £1.6K | +86.0% ▲ |
| Rosuvastatin calcium | 563 | 28.0K | £861 | -37.3% ▼ |
| Gabapentin | 560 | 70.1K | £3.9K | -43.9% ▼ |
| Other emollient preparations | 553 | 306.1K | £4.0K | -7.9% ▼ |
| Atenolol | 541 | 26.0K | £575 | -10.3% ▼ |
| Estradiol with progestogen | 532 | 25.6K | £17.7K | +56.1% ▲ |
| Venlafaxine | 526 | 33.2K | £4.3K | -37.7% ▼ |
| 516 | 67.1K | £3.2K | +8.8% ▲ | |
| Solifenacin | 508 | 19.1K | £985 | +6.5% ▲ |
| Alginic acid compound preparations | 502 | 264.9K | £3.1K | -14.3% ▼ |
| Insulin aspart | 501 | 3,698 | £23.3K | +31.6% ▲ |
| Desogestrel | 500 | 71.3K | £2.3K | +26.1% ▲ |
| Gliclazide | 488 | 41.7K | £1.2K | -42.6% ▼ |
| Mirabegron | 480 | 16.8K | £15.5K | +19.5% ▲ |
| Latanoprost | 480 | 8,658 | £3.1K | -1.1% vs avg |
| Carbocisteine | 474 | 117.8K | £2.5K | -11.2% ▼ |
| Cetirizine hydrochloride | 471 | 27.3K | £997 | -5.7% ▼ |
| Ezetimibe | 462 | 19.9K | £3.5K | -35.1% ▼ |
| Lamotrigine | 455 | 41.3K | £4.6K | -23.0% ▼ |
| Lidocaine hydrochloride | 444 | 5,203 | £9.4K | +157.4% ▲ |
| Senna | 433 | 19.2K | £427 | -28.0% ▼ |
| Combined ethinylestradiol 30mcg | 430 | 46.1K | £2.7K | +54.8% ▲ |
| Levetiracetam | 428 | 79.3K | £7.0K | -6.5% ▼ |
| Memantine hydrochloride | 424 | 12.7K | £1.2K | +28.4% ▲ |
| Oxycodone hydrochloride | 407 | 37.3K | £6.8K | +59.0% ▲ |
| Bumetanide | 401 | 17.9K | £2.3K | +47.2% ▲ |
| Edoxaban | 387 | 15.1K | £25.0K | -44.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.